(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OVA1PLUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

OVA1PLUS

ST13

US500000088962003

Class

44

Filing

88962003

Registration

6249278

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

14

Latest update

01/20/2026

Trademark type

Combined

Nice classes

44

Filing date

06/12/2020

Registration date

01/19/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/19/2021

Last transaction

01/20/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

2018-10-00

First use in commerce

2018-10-00

Drawing code

3

Owner type

03

Owner location

Austin, TX

Examiner

ALAO,OREOLUWA

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the term "OVA" written in a stylized script followed by the number "1" inside a shaded circle followed by the term "PLUS". The number "1" inside the circle and the term "PLUS" are in a superscript position to the right of the term "OVA".

Holders and representatives

Holders

ASPIRA WOMEN'S HEALTH INC.

Representatives

MELISSA HUNTER-ENSOR GREENBERG TRAURIG, LLP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical testing for diagnostic or treatment purposes in the field of oncology; medical testing for diagnostic or treatment purposes in the field of gynecology and women's health; medical diagnosis of cancer; Medical information servicesreporting of consumer authorized clinical testing results directly to the patient

Publications

History of USPTO decisions and trademark events.

14 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/19/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

01/19/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/03/2020

PUBO

PUBLISHED FOR OPPOSITION

11/03/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/14/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/23/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

09/23/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/23/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

09/23/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/23/2020

DOCK

ASSIGNED TO EXAMINER

09/16/2020

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/11/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/10/2020

NWAP

NEW APPLICATION ENTERED

06/16/2020

Continuous trademark protection

Get notified about every new filing that threatens OVA1PLUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.